Andrew Oxtoby
Directeur/Membre du Conseil chez Damien Center
Postes actifs de Andrew Oxtoby
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Damien Center | Directeur/Membre du Conseil | - | - |
Historique de carrière de Andrew Oxtoby
Anciens postes connus de Andrew Oxtoby
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 15/02/2023 | 09/08/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Lilly Nederland Holding BV
 Lilly Nederland Holding BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Nederland Holding BV provides investment services. The company is based in Utrecht, Netherlands. | Corporate Officer/Principal | 01/12/2009 | 01/04/2012 |
| AIMMUNE THERAPEUTICS, INC. | Directeur Général | - | - |
| Corporate Officer/Principal | 22/01/2019 | - | |
| President | - | - |
Formation de Andrew Oxtoby
| Purdue University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
| Pays-Bas | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 4 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Damien Center | |
Lilly Nederland Holding BV
Lilly Nederland Holding BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Nederland Holding BV provides investment services. The company is based in Utrecht, Netherlands. | Finance |
- Bourse
- Insiders
- Andrew Oxtoby
- Expérience
